{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:32:26Z","timestamp":1782772346361,"version":"3.54.5"},"reference-count":47,"publisher":"Baishideng Publishing Group Inc.","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJGO"],"published-print":{"date-parts":[[2022,8,15]]},"DOI":"10.4251\/wjgo.v14.i8.1446","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T11:00:17Z","timestamp":1660042817000},"page":"1446-1455","source":"Crossref","is-referenced-by-count":8,"title":["Immunotherapy in biliary tract cancers: Current evidence and future perspectives"],"prefix":"10.4251","volume":"14","author":[{"given":"Pedro Luiz Serrano","family":"Uson Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael LC","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"B2","unstructured":"NCCN.   Hepatobiliary Cancers, NCCN guidelines version 2. 2021. [Accessed 1 May 2021] Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary.pdf"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-020-04079-z"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000606"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.4015"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30157-1"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30109-1"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-021-01170-x"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.860453"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61903-0"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0116-x"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1795-7"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.4012"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2021.1853527"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/1073274820948047"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2021.1897102"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.4_suppl.378"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2016.10.04"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15180"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-018-0064-z"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017699"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80011"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00396"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1709968"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3410\/f.736855157.793571317"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e16670"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.4589"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30445-9"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy282.009"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.4079"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2019.493"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0930"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.4074"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e15195"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcaa002"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.031"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.4588"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.4582"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.4520"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.3_suppl.321"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.4096"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1352"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-018-1993-1"},{"key":"B47","unstructured":"AstraZeneca.   Imfinzi plus chemotherapy significantly improved overall survival in 1st-line advanced biliary tract cancer in TOPAZ-1 Phase III trial at interim analysis. 2021. [Accessed on November 23, 2021] Available from: https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2021\/imfinzi-improved-survival-in-biliary-tract-cancer.html"}],"container-title":["World Journal of Gastrointestinal Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-5204\/full\/v14\/i8\/1446.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T11:01:06Z","timestamp":1660042866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-5204\/full\/v14\/i8\/1446.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":47,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.4251\/wjgo.v14.i8.1446","relation":{},"ISSN":["1948-5204"],"issn-type":[{"value":"1948-5204","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,15]]}}}